Trial Profile
A comparative efficacy study of rotavirus vaccination using RotaTeq and Rotarix in Taiwanese infants.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2014
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary) ; Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 18 Apr 2014 New trial record
- 01 Mar 2014 Results published in the Pediatric Infectious Disease Journal.